[ by Ian Le Guillou, Department of Biochemistry, University of Cambridge ]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”} [Although contradictory to the hopes of the Access to Understanding competition, writing about the work described in ]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”}[’NLK is a Novel Therapeutic Target for PTEN Deficient Tumour Cells’]{style=“color: black;

[[By Claire Sand, Institute of Pharmaceutical Science, King’s College London]{style=“color: #5a595e; font-family: "arial" , "sans-serif";”}]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”} [The Access to Understanding competition had instant appeal for me because it seemed to combine my two greatest interests – science and writing.

Earlier this month HEFCE invited advice on developing their open access policy in the post-2014 Research Excellence Framework (REF). Both EMBL-EBI, who run the Europe PubMed Central (Europe PMC) service, and the UK members of the Europe PMC Funders’ Group, strongly support HEFCE’s movement towards requiring that all outputs submitted to the post-2014 REF are published open access.

[By ]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”}[Emma Pewsey, Department of Materials Science, University of Cambridge.]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”} [I’m a relative newcomer to biosciences – at school, physics and chemistry were more my thing. However, starting a PhD on the corrosion of metal implants in the human body meant I needed to brush up on my biology.

[Europe PMC is pleased to release a new RESTful Web Service, in addition to the existing SOAP service. Both Web Services can be accessed via the ‘Resources’ menu option on the Europe PMC ]{style=“font-family: "trebuchet ms" , sans-serif;”}[homepage]{style=“font-family: "trebuchet ms" , sans-serif;”}[.]{style=“font-family: "trebuchet ms" , sans-serif;”} []{style=“color: #5a595e;

[We were delighted to announce the winners of the Access to Understanding science-writing competition at an awards ceremony held last night (11 March) at The British Library in London.]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”} []{style=“font-family: "arial";”} [Entrants to the ]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”}[competition were challenged to summarise a

On the 1st April 2013, both the Wellcome Trust and the Research Councils UK will require that any article which attributes their funding and incurs an Article Processing Charge (APC) must be licensed using the Creative Commons Attribution license (CC-BY). This blog posting provides an update as to those publishers who publish high volumes of Europe PMC funded research and who have put information in the public domain to confirm whether

Access to Understanding is a new science-writing competition, developed by Europe PubMed Central and The British Library, aimed at early career researchers and PhD students.  The winner will receive an iPad and have their entry published in eLife.

We are delighted to launch Europe PubMed Central (Europe PMC), which reflects a growing commitment from European Life Sciences research funders to make their research freely available around the world. As announced in July, the European Research Council (ERC) becomes the third European funder to join UKPMC, following Telethon Italy and the Austrian Research Fund.

eLife [, the new open-access journal for outstanding scientific advancements, has ]{style=“font-family: "arial" , "helvetica" , sans-serif;”}published[ its first four research articles.]{style=“font-family: "arial" , "helvetica" , sans-serif;”} [ ]{style=“font-family: "arial" , "helvetica" , sans-serif;”} [First announced in summer 2011, eLife is a researcher-led initiative for the best in science and science communication.